标题
Malaria vaccines since 2000: progress, priorities, products
作者
关键词
-
出版物
npj Vaccines
Volume 5, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-06-09
DOI
10.1038/s41541-020-0196-3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study
- (2020) Sodiomon B Sirima et al. LANCET INFECTIOUS DISEASES
- WHO’s malaria vaccine study represents a “serious breach of international ethical standards”
- (2020) Peter Doshi BMJ-British Medical Journal
- Anti-PfGARP activates programmed cell death of parasites and reduces severe malaria
- (2020) Dipak K. Raj et al. NATURE
- First-in-human, randomized, double-blind clinical trial of differentially adjuvanted PAMVAC, a vaccine candidate to prevent pregnancy-associated malaria
- (2019) Benjamin Mordmüller et al. CLINICAL INFECTIOUS DISEASES
- Safety, toxicity and immunogenicity of a malaria vaccine based on the circumsporozoite protein (FMP013) with the adjuvant army liposome formulation containing QS21 (ALFQ)
- (2019) Alicia Cawlfield et al. VACCINE
- Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibody
- (2019) Thomas. A. Rawlinson et al. Nature Microbiology
- Structural basis for neutralization of Plasmodium vivax by naturally acquired human antibodies that target DBP
- (2019) Darya Urusova et al. Nature Microbiology
- Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies
- (2019) Daniel G.W. Alanine et al. CELL
- Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000–17: a spatial and temporal modelling study
- (2019) Katherine E Battle et al. LANCET
- Pfs230 and Pfs48/45 Fusion Proteins Elicit Strong Transmission-Blocking Antibody Responses Against Plasmodium falciparum
- (2019) Susheel K. Singh et al. Frontiers in Immunology
- Protective Immunity against Severe Malaria in Children Is Associated with a Limited Repertoire of Antibodies to Conserved PfEMP1 Variants
- (2019) Sofonias K. Tessema et al. Cell Host & Microbe
- Diverse Antibody Responses to Conserved Structural Motifs in Plasmodium falciparum Circumsporozoite Protein
- (2019) Tossapol Pholcharee et al. JOURNAL OF MOLECULAR BIOLOGY
- A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite protein
- (2018) Joshua Tan et al. NATURE MEDICINE
- A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite
- (2018) Neville K Kisalu et al. NATURE MEDICINE
- Antihomotypic affinity maturation improves human B cell responses against a repetitive epitope
- (2018) Katharina Imkeller et al. SCIENCE
- Assessment of Antibodies Induced by Multivalent Transmission-Blocking Malaria Vaccines
- (2018) Vinay Menon et al. Frontiers in Immunology
- Production, quality control, stability, and potency of cGMP-produced Plasmodium falciparum RH5.1 protein vaccine expressed in Drosophila S2 cells
- (2018) Jing Jin et al. npj Vaccines
- Malaria vaccine candidate based on Duffy-binding protein elicits strain transcending functional antibodies in a Phase I trial
- (2018) Kavita Singh et al. npj Vaccines
- Vaccination with chemically attenuated Plasmodium falciparum asexual blood-stage parasites induces parasite-specific cellular immune responses in malaria-naïve volunteers: a pilot study
- (2018) Danielle I. Stanisic et al. BMC Medicine
- Cryo-EM structure of P. falciparum circumsporozoite protein with a vaccine-elicited antibody is stabilized by somatically mutated inter-Fab contacts
- (2018) David Oyen et al. Science Advances
- Natural Parasite Exposure Induces Protective Human Anti-Malarial Antibodies
- (2017) Gianna Triller et al. IMMUNITY
- Rare PfCSP C-terminal antibodies induced by live sporozoite vaccination are ineffective against malaria infection
- (2017) Stephen W. Scally et al. JOURNAL OF EXPERIMENTAL MEDICINE
- γδ T Cells Are Required for the Induction of Sterile Immunity during Irradiated Sporozoite Vaccinations
- (2017) Irfan Zaidi et al. JOURNAL OF IMMUNOLOGY
- Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial
- (2017) Mahamadou S Sissoko et al. LANCET INFECTIOUS DISEASES
- Construct design, production, and characterization of Plasmodium falciparum 48/45 R0.6C subunit protein produced in Lactococcus lactis as candidate vaccine
- (2017) Susheel K. Singh et al. Microbial Cell Factories
- Sterile protection against human malaria by chemoattenuated PfSPZ vaccine
- (2017) Benjamin Mordmüller et al. NATURE
- Adjuvant and carrier protein-dependent T-cell priming promotes a robust antibody response against the Plasmodium falciparum Pfs25 vaccine candidate
- (2017) Andrea J. Radtke et al. Scientific Reports
- Advances in malaria vaccine development: report from the 2017 malaria vaccine symposium
- (2017) Camila Henriques Coelho et al. npj Vaccines
- A malaria vaccine protects Aotus monkeys against virulent Plasmodium falciparum infection
- (2017) Prakash Srinivasan et al. npj Vaccines
- Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine
- (2017) Katharine A. Collins et al. Scientific Reports
- Chemically Attenuated Blood-Stage Plasmodium yoelii Parasites Induce Long-Lived and Strain-Transcending Protection
- (2016) Amber I. Raja et al. INFECTION AND IMMUNITY
- Persistence and immunogenicity of chemically attenuated blood stage Plasmodium falciparum in Aotus monkeys
- (2016) Sai Lata De et al. INTERNATIONAL JOURNAL FOR PARASITOLOGY
- Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of thePlasmodium falciparumSexual Stage Protein Pfs230
- (2016) Nicholas J. MacDonald et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Demonstration of the Blood-StagePlasmodium falciparumControlled Human Malaria Infection Model to Assess Efficacy of theP. falciparumApical Membrane Antigen 1 Vaccine, FMP2.1/AS01
- (2016) Ruth O. Payne et al. JOURNAL OF INFECTIOUS DISEASES
- Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study
- (2016) Jason A. Regules et al. JOURNAL OF INFECTIOUS DISEASES
- Protection against malaria at 1 year and immune correlates following PfSPZ vaccination
- (2016) Andrew S Ishizuka et al. NATURE MEDICINE
- A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children
- (2016) Sodiomon B. Sirima et al. VACCINE
- Protective Efficacy of Plasmodium vivax Radiation-Attenuated Sporozoites in Colombian Volunteers: A Randomized Controlled Trial
- (2016) Myriam Arévalo-Herrera et al. PLoS Neglected Tropical Diseases
- Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults
- (2016) Kawsar R. Talaat et al. PLoS One
- Production of full-length soluble Plasmodium falciparum RH5 protein vaccine using a Drosophila melanogaster Schneider 2 stable cell line system
- (2016) Kathryn A. Hjerrild et al. Scientific Reports
- A PfRH5-Based Vaccine Is Efficacious against Heterologous Strain Blood-Stage Plasmodium falciparum Infection in Aotus Monkeys
- (2015) Alexander D. Douglas et al. Cell Host & Microbe
- Reversible Conformational Change in the Plasmodium falciparum Circumsporozoite Protein Masks Its Adhesion Domains
- (2015) Raul Herrera et al. INFECTION AND IMMUNITY
- Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine
- (2015) Daniel E. Neafsey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines
- (2015) Thomas L. Richie et al. VACCINE
- Designing a VAR2CSA-based vaccine to prevent placental malaria
- (2015) Michal Fried et al. VACCINE
- The march toward malaria vaccines
- (2015) Stephen L. Hoffman et al. VACCINE
- Comparative Assessment of Transmission-Blocking Vaccine Candidates against Plasmodium falciparum
- (2015) M. C. Kapulu et al. Scientific Reports
- Antibodies to PfSEA-1 block parasite egress from RBCs and protect against malaria infection
- (2014) D. K. Raj et al. SCIENCE
- Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites
- (2014) PLOS MEDICINE
- Protective Efficacy of a Plasmodium vivax Circumsporozoite Protein-Based Vaccine in Aotus nancymaae Is Associated with Antibodies to the Repeat Region
- (2014) Anjali Yadava et al. PLoS Neglected Tropical Diseases
- Evidence and Implications of Mortality Associated with Acute Plasmodium vivax Malaria
- (2013) J. Kevin Baird CLINICAL MICROBIOLOGY REVIEWS
- Cross-species malaria immunity induced by chemically attenuated parasites
- (2013) Michael F. Good et al. JOURNAL OF CLINICAL INVESTIGATION
- Naturally Acquired Antibodies Specific for Plasmodium falciparum Reticulocyte-Binding Protein Homologue 5 Inhibit Parasite Growth and Predict Protection From Malaria
- (2013) Tuan M. Tran et al. JOURNAL OF INFECTIOUS DISEASES
- Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine
- (2013) R. A. Seder et al. SCIENCE
- Anti-Plasmodium falciparum invasion ligand antibodies in a low malaria transmission region, Loreto, Peru
- (2012) Elizabeth Villasis et al. MALARIA JOURNAL
- A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Protective CD8+ T lymphocytes in Primates Immunized with Malaria Sporozoites
- (2012) Walter R. Weiss et al. PLoS One
- Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study
- (2011) Meta Roestenberg et al. LANCET
- Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum
- (2011) Cécile Crosnier et al. NATURE
- Protection against Malaria by MSP3 Candidate Vaccine
- (2011) Sodiomon B. Sirima et al. NEW ENGLAND JOURNAL OF MEDICINE
- Live Attenuated Malaria Vaccine Designed to Protect Through Hepatic CD8+ T Cell Immunity
- (2011) J. E. Epstein et al. SCIENCE
- The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody
- (2011) Alexander D. Douglas et al. Nature Communications
- A Research Agenda for Malaria Eradication: Vaccines
- (2011) PLOS MEDICINE
- Development of a metabolically active, non-replicating sporozoite vaccine to preventPlasmodium falciparummalaria
- (2010) Stephen L. Hoffman et al. Human vaccines & immunotherapeutics
- Protection against a Malaria Challenge by Sporozoite Inoculation
- (2009) Meta Roestenberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A
- (2009) Michele D. Spring et al. PLoS One
- Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area
- (2009) Mark E. Polhemus et al. PLoS One
- Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51
- (2008) Yimin Wu et al. PLoS One
- The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity
- (2008) Silayuv E. Bongfen et al. VACCINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started